Cancer Family

Pancreaticobiliary Neoplasm

Non-malignant1,205 active trials11 approved drugs92 evidence items

NCIt: C223357

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (304)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 201–225 of 304 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Treatment of elderly patients with advanced (M1) gallbladder cancer - Aggressive or conservative?: A retrospective cohort study based on the SEER database.
Bin He, Ti Zhou, Penghua Weng et al. · Medicine (Baltimore) · Aug 28, 2026 · PMID 42675723 · candidate dictionary pubmed
Human Gallbladder Cancer Organoids.
Dongxi Xiang, Ting Gong, Yinjie Zhu et al. · Cell Prolif · Aug 27, 2026 · PMID 42657495 · candidate dictionary pubmed
Per Protocol Analysis and Long-Term Outcomes of Laparoscopic Radical Resection for Gallbladder Cancer Compared With Open Method.
Tae Ho Hong, Kwang Yeol Paik, Yoon Kyung Woo et al. · World J Surg · Aug 24, 2026 · PMID 42635447 · candidate dictionary pubmed
EXPRESSION PATTERNS AND CLINICAL SIGNIFICANCE OF ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2/neu IN GALLBLADDER CANCER.
Deepti Mishra, Akhilesh Krishna, Priyanka Sameer et al. · Exp Oncol · Aug 21, 2026 · PMID 42634843 · candidate dictionary pubmed
Design of Receptor-Specific Anticancer Agents for Gallbladder Cancer: Integrating Immunomodulatory Strategies.
Deepika Verma, Parag Jain, Heena Rathod et al. · Anticancer Agents Med Chem · Aug 17, 2026 · PMID 42670003 · candidate dictionary pubmed
Systemic treatment of advanced pancreatic cancer: A Comprehensive Review.
Jamshed Ali, Maria Qubtia, Amer Rehman Farrooqi et al. · J Cancer Allied Spec · Mar 1, 2026 · PMID 42725320 · candidate dictionary pubmed

Analgesic patterns and predictors of opioid consumption following epidural analgesia discontinuation after pancreatic cancer surgery.

Samuel Fredriksson, Christina Biörserud, Johanna Wennerblom et al. · Scand J Pain · Jan 1, 2026 · PMID 42714852 · candidate dictionary pubmed

Mortality trends of gallbladder cancer in middle-aged and older adults in the United States: a CDC WONDER analysis from 1999 to 2023.

Qiuxuan Yang, Xu Chen, Yao Xiao et al. · Front Oncol · Jan 1, 2026 · PMID 42656277 · candidate dictionary pubmed

Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer.

Ali Afgar, Saeed Zanganeh, Roohollah Mirzaee Khalilabadi et al. · In Silico Pharmacol · Jan 1, 2026 · PMID 42707300 · candidate dictionary pubmed

Patient-specific integration of RNA expression, methylation-derived replication-timing proxies, and histomorphology for pancreatic cancer subtyping.

Alejandro Leyva, M Khalid Khan Niazi · PLoS One · Jan 1, 2026 · PMID 42743314 · candidate dictionary pubmed

Machine learning-supported identification of necrosis in colorectal and pancreatic cancer spheroids.

Miguel Martínez Lozano, Heinz D Wanzenboeck, Sonia Prado-López · PLoS One · Jan 1, 2026 · PMID 42743162 · candidate dictionary pubmed

Differences of Statin Activity in 2D and 3D Pancreatic Cancer Cell Cultures [Expression of Concern].

· Drug Des Devel Ther · Jan 1, 2026 · PMID 42787175 · candidate dictionary pubmed

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

· N Engl J Med · 2019 · PMID 31157963 · validated civic_curation pubmed

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.

· Lancet Oncol · 2020 · PMID 32416072 · validated civic_curation pubmed

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.

· Lancet Oncol · 2020 · PMID 32203698 · validated civic_curation pubmed

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.

· Lancet Gastroenterol Hepatol · 2021 · PMID 34358484 · validated civic_curation pubmed

Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.

· N Engl J Med · 2025 · PMID 39908431 · validated civic_curation pubmed

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.

· Eur J Cancer · 2014 · PMID 24915778 · validated civic_curation pubmed

Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy.

· Mol Cancer Ther · 2011 · PMID 21862683 · validated civic_curation pubmed

Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.

· J Gastroenterol · 2013 · PMID 22983505 · validated civic_curation pubmed

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.

· Clin Transl Gastroenterol · 2016 · PMID 27010960 · validated civic_curation pubmed

Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.

· Hepatology · 2014 · PMID 24122810 · validated civic_curation pubmed

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.Retracted

· N Engl J Med · 2015 · PMID 26287849 · validated civic_curation pubmed

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

· J Clin Oncol · 2018 · PMID 29182496 · validated civic_curation pubmed

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

· J Clin Oncol · 2015 · PMID 25366685 · validated civic_curation pubmed